- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | IMAC Holdings, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | - | SEC Filings | ||
| 14.11. | Imac Holdings-Aktie erreicht 52-Wochen-Tief bei 1,02 US-Dollar | 2 | Investing.com Deutsch | ||
| 14.11. | Imac Holdings stock hits 52-week low at $1.02 | 1 | Investing.com | ||
| IMAC HOLDINGS Aktie jetzt für 0€ handeln | |||||
| 14.11. | IMAC Holdings, Inc.: IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c) | 62 | GlobeNewswire (Europe) | FRANKLIN, TN, Nov. 14, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it has received an exception from the Listing Qualifications Staff... ► Artikel lesen | |
| 13.11. | IMAC Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 23.10. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 26.09. | IMAC Holdings welcomes Jeffrey Busch to its Board of Directors | 2 | Investing.com | ||
| 25.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | Imac Holdings stock hits 52-week low at $1.2 amid market challenges | 1 | Investing.com | ||
| 19.09. | IMAC Holdings, Inc.: IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology | 1 | GlobeNewswire (USA) | ||
| 13.09. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.08. | IMAC Holdings receives notification of deficiency from Nasdaq | 1 | Seeking Alpha | ||
| 23.08. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.08. | IMAC Holdings, Inc.: IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q | 339 | GlobeNewswire (Europe) | FRANKLIN, TN, Aug. 23, 2024 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. ("IMAC" or the "Company") (NASDAQ: BACK) today announced that it received an expected deficiency notification letter from the Listing... ► Artikel lesen | |
| 30.07. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.07. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 11.07. | IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors | 1 | GlobeNewswire (USA) | ||
| 02.07. | IMAC Holdings, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.06. | IMAC Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 14.06. | IMAC Holdings files to sell common stock and warrants, size not disclosed | 2 | Seeking Alpha |
Seite:
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 1,154 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients with leptomeningeal metastases (LM) Presented positive... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
| LIFEWARD | 1,840 | 0,00 % | Lifeward Ltd.: Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons | ||
| EKSO BIONICS | 0,710 | +5,34 % | Ekso Bionics stock plunges to 52-week low of $0.71 | ||
| IMUNON | 0,635 | -2,31 % | Imunon, Inc.: IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting | IMNN-001 immunotherapy plus standard-of-care chemotherapy resulted in 35% improvement in overall survival and 25% improvement in progression-free survival versus standard-of-care alone Treatment was... ► Artikel lesen | |
| ROCKWELL MEDICAL | 2,280 | +3,35 % | Rockwell Medical-Direktor Mark H. Ravich verkauft Aktien im Wert von 70.379 US-Dollar | ||
| AVINGER | 0,770 | 0,00 % | Avinger-Aktie erreicht 52-Wochen-Tief bei 0,75 US-Dollar | ||
| VIRIDIAN THERAPEUTICS | 18,800 | 0,00 % | Viridian Therapeutics Reports Third Quarter 2024 Financial Results and Recent Progress Including New FcRn Data | WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company focused on discovering and developing potential best-in-class medicines for serious and rare... ► Artikel lesen | |
| SINTX TECHNOLOGIES | 3,720 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Provides Positive Strategic Business Update for Q3 2024 | Salt Lake City, UT, Nov. 14, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) ("SINTX" or the "Company"), an advanced ceramics company that develops and commercializes materials, components... ► Artikel lesen | |
| AETHLON MEDICAL | 0,328 | 0,00 % | AETHLON MEDICAL INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order | TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
| NEURONETICS | 0,723 | +6,32 % | Greenbrook Receives Final Court Approval For Arrangement With Neuronetics | ||
| ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
| HVIVO | 0,236 | 0,00 % | hVIVO PLC - Presentation at Jefferies London Healthcare Conf |
IMAC HOLDINGS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMAC HOLDINGS INC finden Sie auf Wallstreet Online.
